These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 14613222)
21. Surface modification of PLGA particles: the interplay between stabilizer, ligand size, and hydrophobic interactions. Ratzinger G; Länger U; Neutsch L; Pittner F; Wirth M; Gabor F Langmuir; 2010 Feb; 26(3):1855-9. PubMed ID: 19810705 [TBL] [Abstract][Full Text] [Related]
22. Protein-loaded PLGA-PEG-PLGA microspheres: a tool for cell therapy. Tran VT; Karam JP; Garric X; Coudane J; Benoît JP; Montero-Menei CN; Venier-Julienne MC Eur J Pharm Sci; 2012 Jan; 45(1-2):128-37. PubMed ID: 22085679 [TBL] [Abstract][Full Text] [Related]
23. Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles. Chae JM; Mo SM; Oh IJ J Nanosci Nanotechnol; 2010 May; 10(5):3224-7. PubMed ID: 20358927 [TBL] [Abstract][Full Text] [Related]
24. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647 [TBL] [Abstract][Full Text] [Related]
25. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study. Zheng S; Luo L; Bo R; Liu Z; Xing J; Niu Y; Hu Y; Liu J; Wang D Int J Nanomedicine; 2016; 11():4891-4904. PubMed ID: 27729787 [TBL] [Abstract][Full Text] [Related]
27. Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. Ngaboni Okassa L; Marchais H; Douziech-Eyrolles L; Cohen-Jonathan S; Soucé M; Dubois P; Chourpa I Int J Pharm; 2005 Sep; 302(1-2):187-96. PubMed ID: 16099119 [TBL] [Abstract][Full Text] [Related]
28. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Tahara K; Furukawa S; Yamamoto H; Kawashima Y Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023 [TBL] [Abstract][Full Text] [Related]
29. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508 [TBL] [Abstract][Full Text] [Related]
30. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Shakweh M; Besnard M; Nicolas V; Fattal E Eur J Pharm Biopharm; 2005 Sep; 61(1-2):1-13. PubMed ID: 16005619 [TBL] [Abstract][Full Text] [Related]
31. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications. Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320 [TBL] [Abstract][Full Text] [Related]
32. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Beletsi A; Panagi Z; Avgoustakis K Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907 [TBL] [Abstract][Full Text] [Related]
33. Preparation, characterization and nasal delivery of alpha-cobrotoxin-loaded poly(lactide-co-glycolide)/polyanhydride microspheres. Li Y; Jiang HL; Zhu KJ; Liu JH; Hao YL J Control Release; 2005 Nov; 108(1):10-20. PubMed ID: 16125269 [TBL] [Abstract][Full Text] [Related]
34. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo. Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688 [TBL] [Abstract][Full Text] [Related]
36. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier. Chen YC; Hsieh WY; Lee WF; Zeng DT J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601 [TBL] [Abstract][Full Text] [Related]
37. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation. Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238 [TBL] [Abstract][Full Text] [Related]
38. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. Choi SW; Kim JH J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158 [TBL] [Abstract][Full Text] [Related]
39. In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models. Falabella CA; Jiang H; Frame MD; Chen W J Biomater Sci Polym Ed; 2009; 20(7-8):903-22. PubMed ID: 19454159 [TBL] [Abstract][Full Text] [Related]
40. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents. Gano L; Marques F; Campello MP; Balbina M; Lacerda S; Santos I Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):6-15. PubMed ID: 17372568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]